June or July of this year they are waiting FDA approval for their OTC drug candidate called Fluticare, by that time this will reach $1.00. I discovered this when it was just 0.05, didn't pay to much attention to, then checked back with it few months later, it was sitting at .10, again didn't pay too much attention to it. Until most recently found out that their OTC drug, just based on speculation can take this to $1.00, extremely low O/S of which half is owned by insiders, only 68 million O/S. They have products in the market that they are selling already, plus the CEO is working to get an uplisting on the big board, although that is not his focus yet, they have numerous drugs on the market right now, they have sales, I think if FDA gets approved this will jump to $2.00. Peeps are thinking that this could be better than AVXL. I got in at 0.25, should have got in at 0.10, but you know how hesitant I am with pennies. But I see potential. There is a lot of positive remarks on its board, never questioned anybody though, just reading through some of their posts and impressive, some peeps make compelling debate the potential of this little pharma. I think it fly to 40+ Monday, impressive action for the past one week. I started watching it since Monday on level 2, but hesitant to pull the trigger, but finally got in at 0.25 yesterday. Check it out and let me know what you think. I think from here the possibility of 300% gain is not too far fetched until the FDA approval. Apparently they have 11 products already in their pipeline, they just recently bought another pharma with actual products that were being sold already in the market through distribution.
AI
